Drug Approval Process
The drug approval process involves several key steps to ensure a new medication is safe and effective. First, researchers conduct laboratory and animal studies. If results are promising, they move to clinical trials with human volunteers, which occur in three phases to assess safety and effectiveness at increasing doses. After successful trials, the company submits data to regulatory authorities, like the FDA in the U.S., for review. If approved, the drug can be marketed. Post-approval, ongoing monitoring ensures long-term safety. This rigorous process helps protect public health while allowing new treatments to reach those in need.
Additional Insights
-
The drug approval process involves several key steps to ensure safety and effectiveness. First, researchers conduct laboratory tests and animal studies. If results are promising, they submit an Investigational New Drug (IND) application to regulatory authorities for approval to begin human testing. This is followed by three phases of clinical trials: Phase 1 tests safety in a small group, Phase 2 assesses efficacy and side effects in a larger group, and Phase 3 involves thousands to confirm effectiveness and monitor adverse reactions. Finally, the data is submitted in a New Drug Application (NDA) for regulatory review before the drug can be marketed.